Keppra Oral Tablet 1000Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Keppra: Oral tablet (1000mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_8412.JPG
Keppra 1000mg Tab
UCB Pharma Inc
Pill Identification: ucb 1000 

What is this Medicine?

LEVETIRACETAM (lee ve tye RA se tam) is an antiepileptic drug. It is used with other medicines to treat certain types of seizures.

CVS Pharmacy Patient Statistics for Keppra: Oral tablet(1000mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Keppra 1000mg Tablet

NDC: 504740597
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Partial Seizures

Sometimes used for but not FDA approved for the following conditions:
Tonic-clonic Seizures, Status Epilepticus, Myoclonic Seizures, Seizure Prophylaxis

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Protect from extreme heat
Keppra 1000mg Tablet
Drug Image file DrugItem_8412.JPG
UCB Pharma Inc
Pill Identification: ucb 1000 
Shape: oblong
Color: white

Reported Side Effects for Keppra 1000mg Tablet

Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<9.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Drug Reaction With Eosinophilia And Systemic Symptoms (DRESS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
<17.0%*
Severity: MODERATE
Onset: EARLY
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Thoughts Of Suicide Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Psychosis Incidence:
1.0-17.0%*
Severity: MODERATE
Onset: EARLY
Hallucinations Incidence:
1.0-17.0%*
Severity: MODERATE
Onset: EARLY
Paranoia Incidence:
1.6%*
Severity: MILD
Onset: EARLY
Dehydration Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Emotional Lability Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
2.0-11.0%*
Severity: MILD
Onset: DELAYED
Hostility Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
2.0-8.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Ear Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Loss Of Memory Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
3.0-13.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
3.0-8.0%*
Severity: MILD
Onset: DELAYED
Protein In The Urine Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Bruise Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
4.0-13.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Tiredness Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
6.0-11.7%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
6.0-10.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Eosinophilia Incidence:
8.6%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
9.0-15.0%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
15.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Second Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Third Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Keppra

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.